The Cigna Group Reports Fourth Quarter and Full Year 2024 Results, Establishes 2025 Outlook and Increases Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Raymond James Reiterates Strong Buy Rating on CIGNA (CI)
January 30, 2025 8:44 AM ESTRaymond James analyst John Ransom reiterated a Strong Buy rating and $415.00 price target on CIGNA (NYSE: CI)
The analyst comments "Event: This morning, Cigna reported 4Q24 results that significantly missed expectations, with adj. revenue of $65.7B (Street: $63.1B; RJ: $64.9B), adj. EBT of $2.23B (Street $2.78B; RJ: $2.84B), and adj. EPS of $6.64 (Street: $7.82; RJ: $7.78), while MLR came in at 87.9% (Street: 84.7%, RJ: 84.9%). At first glance, the main highlight of the... More
BofA on CIGNA (CI): 'Quarter and outlook disappoint, valuation pressured'
January 30, 2025 8:37 AM ESTBofA Securities analyst Adam Ron reiterated a Buy rating and $420.00 price target on CIGNA (NYSE: CI).
The analyst comments "CI unexpectantly missed 4Q earnings by 13% in the quarter ($1.03), and lowered its view of 2025 by $1.74 (6%). With the new outlook, the company is now... More
